Oncology - European Medical Journal

Continue

Oncology

Filter
9 Oct 2017

Advanced Stage III Melanoma: Brand New Adjuvant Therapy Discovered

A NOVEL combination of dabrafenib and trametinib has proven a successful adjuvant therapy for Stage III BRAF-mutant melanoma patients, doubling…
11 Sep 2017

Robust Performance of OncoBEAM™ RAS CRC Liquid Biopsy Testing in Routine Clinical Practice for Colorectal Cancer Patients Highlighted at ESMO 2017

Hamburg, Germany, 08 September, 2017 – Sysmex Inostics, a subsidiary of Sysmex Corporation, a global leader in blood based circulating tumor DNA (ctDNA)…
30 Aug 2017

Philips supports global transformation of pathology with two new fully digitized labs in Austria

Amsterdam, 29 August, 2017 – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the continued momentum of…
24 Aug 2017

Immatics Initiates Personalized Adoptive Cellular Therapy in Patients with Relapsed And/Or Refractory Solid Cancers Using Its Pioneering Target Warehouse

Immatics announced enrolment of patients into a phase I trial of its first adoptive cellular therapy (ACT) IMA101.
31 Jul 2017

Colorectal Cancer Risk Reduced by a Mediterranean Diet

RISK of colorectal cancer can be reduced by consuming certain components of the Mediterranean diet, according to data presented at the European…
12 Jul 2017

Updated St. Gallen International Breast Cancer Guidelines Reinforce Important Role of Genomic Testing in Treatment of Early Breast Cancer

Geneva, Switzerland, 12 July, 2017 – Genomic Health today announced that the 15th St. Gallen International Breast Cancer Conference Expert Panel endorsed…
11 Jul 2017

Agendia’s MammaPrint® Recommended by ASCO Breast Cancer Guideline in Focused Update Based on Landmark MINDACT Trial Data

ASCO recommends MammaPrint® for clinical high risk, hormone receptor-positive, HER2-negative breast cancer, to inform decisions on withholding chemotherapy
13 Jun 2017

PharmaMar Announces Encouraging Results in Clinical Trials of Lurbinectedin in Endometrial and Breast Cancers

PharmaMar announces encouraging results in clinical trials of Lurbinectedin in endometrial and breast cancers. Find out more
We’ve noticed you’re accessing
from North/South America.